Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Cancer Institute of NJ Investigates Promising Immunotherapy for Toughest Lung Cancers

May 14, 2015 11:47 am | by Seth Augenstein, Digital Reporter | Articles | Comments

Small-cell lung cancer, often caused by smoking, is among the most stubborn diseases in oncology. While it might respond initially to chemotherapy, it often recurs – and comes back even more resistant to treatment. But a new use of a known immunotherapy, bolstering the body’s immune system, is showing some promise against this disease, according to research taking place at the Rutgers Cancer Institute of New Jersey. Read more...


B Vitamin May Prevent Recurrence of Skin Cancers

May 14, 2015 11:33 am | by Ryan Bushey, Associate Editor | Articles | Comments

A study conducted by scientists at Australia’s University of Sydney found that a form of vitamin B3 has the potential to lower the chance of developing skin cancer. Read more...


Bovine TB Infection Depends on Feedback Between Cattle, Badgers

May 14, 2015 9:22 am | by University of Bristol | News | Comments

New research has found that BTB is most likely to be nearly under control in both species taken in isolation, however together, control is likely to be considerably more challenging. Read more...


Damming and Damning Hemorrhagic Fever

May 14, 2015 9:17 am | by University of Montreal | News | Comments

A potential mechanism to combat diseases caused by hemorrhagic fever viruses has been discovered. Read more...


Breakthrough Opens Door to Safer Lupus Drugs

May 14, 2015 9:08 am | by Monash University | News | Comments

Researchers could revolutionize treatments given to lupus sufferers, saving thousands of people each year from serious illness or death caused by secondary infections. Read more...


Roche Announces Phase 2 Study Results for Lung Cancer Immunotherapy

May 14, 2015 9:04 am | News | Comments

Roche announced interim results from a global, randomized Phase 2 study in people with previously treated NSCLC.  Read more...


Drug Target for Asthma Discovered

May 14, 2015 8:57 am | by Wellcome Trust Sanger Institute | News | Comments

The identification of this gene's role could help in the search for asthma therapies. Read more...


Researchers Find New Targets for Anti-Malaria Drugs

May 14, 2015 8:51 am | by MIT | News | Comments

A new target for drug development in the fight against the deadly disease malaria has been discovered by researchers at MIT. Read more...


No Link Found Between PTSD and Cancer Risk

May 13, 2015 1:09 pm | by Boston University | News | Comments

In the largest study to date that examines Post Traumatic Stress Disorder (PTSD) as a risk factor for cancer, researchers from Boston University School of Medicine (BUSM), have shown no evidence of an association. Read more..


Early Data Release Ends Obesity Drug Study

May 13, 2015 12:50 pm | by Stephanie Guzowski, Editor | News | Comments

A safety study of obesity drug Contrave has been terminated after Orexigen Therapeutics released early, misleading trial data, say researchers. Takeda Pharmaceutical is seeking to end its collaboration with Orexigen. Read more...


Orexigen: Statement on Termination of Study, Updates on Contrave Collaboration with Takeda

May 13, 2015 12:39 pm | News | Comments

Orexigen Therapeutics, Inc. Tuesday issued the following statement regarding the termination of the Light Study a cardiovascular (CV) outcomes trial that compared the obesity drug Contrave. Read more...


How Amphetamine Helps You Focus

May 13, 2015 10:40 am | by Ryan Bushey, Associate Editor | Videos | Comments

This video shows the effects ADD medication have on your brain. Read more...


FDA Panel Backs Vertex Combination Pill for Cystic Fibrosis

May 13, 2015 10:11 am | by Matthew Perrone, AP Health Writer - Associated Press | News | Comments

Federal health advisers on Tuesday recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients. Read more...


Out of Breath and Out of Pocket

May 13, 2015 10:06 am | by Jake Miller, Harvard University | News | Comments

After ozone-protecting inhaler ban, asthma patients pay nearly twice as much more per year for inhalers. Read more...


AstraZeneca to Focus on Precision Medicine for Asthma, Heart Disease

May 13, 2015 9:50 am | by Ryan Bushey, Associate Editor | Articles | Comments

Abbot Laboratories and the Montreal Heart Institute will help the company with this project. Read more..



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.